Colorectal Cancer clinical trials in Nevada

6 actively recruiting colorectal cancer trials at 4 sites across Nevada.

Data from ClinicalTrials.gov · last refreshed 2026-10-12

Phase 3 Recruiting Industry

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

The purpose of this study is to learn more about a new medicine called PF-08634404, and how well it works in people with cancer of the colon or rectum (CRC)). The goal is to understand if the new study medicine, combined with chemotherapy …

Sponsor: Pfizer

NCT ID: NCT07222800

Sites in Nevada:

Comprehensive Cancer Centers Of Nevada — Henderson, Nevada
Comprehensive Cancer Centers of Nevada — Henderson, Nevada
Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada
Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada
Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada

View on ClinicalTrials.gov →

Phase 3 Recruiting Network

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

This study is being done to answer the following questions: Is the chance of rectal cancer responding the same if chemotherapy alone is given before limited surgery compared to chemotherapy and radiation therapy given together before limit…

Sponsor: Canadian Cancer Trials Group

NCT ID: NCT06205485

Sites in Nevada:

Renown Regional Medical Center — Reno, Nevada

View on ClinicalTrials.gov →

Phase 3 Recruiting Industry

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Researchers are looking for other ways to treat locally advanced or metastatic colorectal cancer (mCRC) that is unresectable and has a gene mutation called KRAS G12C. Standard (or usual) treatments for this type of colorectal cancer may in…

Sponsor: Merck Sharp & Dohme LLC

NCT ID: NCT06997497

Sites in Nevada:

Comprehensive Cancer Centers of Nevada ( Site 2026) — Las Vegas, Nevada
Renown Regional Medical Center ( Site 0056) — Reno, Nevada

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, pharmacokinetics (PK), preliminary antitumor activity, and effect of biomarkers of zanzalintinib administered alon…

Sponsor: Exelixis

NCT ID: NCT05176483

Sites in Nevada:

Exelixis Clinical Site #55 — Las Vegas, Nevada

View on ClinicalTrials.gov →

NA Recruiting Academic/Other

Family Communications After Genetic Testing

This clinical trial compares patient (proband)-mediated communication to provider-mediated communication for improving genetic testing in first-degree relatives of patients with newly diagnosed colorectal cancer. It is estimated that 30% o…

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT07143487

Sites in Nevada:

Renown Regional Medical Center — Reno, Nevada

View on ClinicalTrials.gov →

Recruiting Academic/Other

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

This study evaluates cancer-related weight and muscle mass loss, symptoms, and physical function (cachexia) in patients undergoing treatment for colorectal, lung, or pancreatic cancer that cannot be removed by surgery (unresectable) or is …

Sponsor: University of Rochester

NCT ID: NCT06073431

Sites in Nevada:

Carson Tahoe Regional Medical Center — Carson City, Nevada
Comprehensive Cancer Centers of Nevada - Henderson — Henderson, Nevada
OptumCare Cancer Care at Seven Hills — Henderson, Nevada
Comprehensive Cancer Centers of Nevada-Southeast Henderson — Henderson, Nevada
Urology Specialists of Nevada - Green Valley — Henderson, Nevada

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-10-12